[HTML][HTML] Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
M Hallé, P Tribout-Jover, AM Lanteigne… - Journal of …, 2015 - Elsevier
Antibody-mediated capture of amyloid-beta (Aβ) in peripheral blood was identified as an
attractive strategy to eliminate cerebral toxic amyloid in Alzheimer's disease (AD) patients …
attractive strategy to eliminate cerebral toxic amyloid in Alzheimer's disease (AD) patients …
[PDF][PDF] Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
R Palmantier, D Larocque - Journal of Immunological Methods, 2015 - academia.edu
Maxime Hallé a, c, Pascale Tribout-Jover a, Anne-Marie Lanteigne a, Jonathan Boulais a,
Julien R. St-Jean a, Rachel Jodoin a, Marie-Pier Girouard a, Florin Constantin a, Annik …
Julien R. St-Jean a, Rachel Jodoin a, Marie-Pier Girouard a, Florin Constantin a, Annik …
Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies.
M Hallé, P Tribout-Jover, AM Lanteigne… - Journal of …, 2015 - europepmc.org
Antibody-mediated capture of amyloid-beta (Aβ) in peripheral blood was identified as an
attractive strategy to eliminate cerebral toxic amyloid in Alzheimer's disease (AD) patients …
attractive strategy to eliminate cerebral toxic amyloid in Alzheimer's disease (AD) patients …
[PDF][PDF] Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
R Palmantier, D Larocque - Journal of Immunological Methods, 2015 - cyberleninka.org
Maxime Hallé a, c, Pascale Tribout-Jover a, Anne-Marie Lanteigne a, Jonathan Boulais a,
Julien R. St-Jean a, Rachel Jodoin a, Marie-Pier Girouard a, Florin Constantin a, Annik …
Julien R. St-Jean a, Rachel Jodoin a, Marie-Pier Girouard a, Florin Constantin a, Annik …
[PDF][PDF] Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
R Palmantier, D Larocque - 2015 - researchgate.net
Maxime Hallé a, c, Pascale Tribout-Jover a, Anne-Marie Lanteigne a, Jonathan Boulais a,
Julien R. St-Jean a, Rachel Jodoin a, Marie-Pier Girouard a, Florin Constantin a, Annik …
Julien R. St-Jean a, Rachel Jodoin a, Marie-Pier Girouard a, Florin Constantin a, Annik …
Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
M Hallé, P Tribout-Jover, AM Lanteigne… - Journal of …, 2015 - infona.pl
Antibody-mediated capture of amyloid-beta (Aβ) in peripheral blood was identified as an
attractive strategy to eliminate cerebral toxic amyloid in Alzheimer's disease (AD) patients …
attractive strategy to eliminate cerebral toxic amyloid in Alzheimer's disease (AD) patients …
[PDF][PDF] Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
R Palmantier, D Larocque - Journal of Immunological Methods, 2015 - scholar.archive.org
Maxime Hallé a, c, Pascale Tribout-Jover a, Anne-Marie Lanteigne a, Jonathan Boulais a,
Julien R. St-Jean a, Rachel Jodoin a, Marie-Pier Girouard a, Florin Constantin a, Annik …
Julien R. St-Jean a, Rachel Jodoin a, Marie-Pier Girouard a, Florin Constantin a, Annik …
Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
M Hallé, P Tribout-Jover, AM Lanteigne… - Journal of …, 2015 - hero.epa.gov
Antibody-mediated capture of amyloid-beta (Aβ) in peripheral blood was identified as an
attractive strategy to eliminate cerebral toxic amyloid in Alzheimer's disease (AD) patients …
attractive strategy to eliminate cerebral toxic amyloid in Alzheimer's disease (AD) patients …
Methods to monitor monocytes-mediated amyloid-beta uptake and phagocytosis in the context of adjuvanted immunotherapies
M Hallé, P Tribout-Jover… - Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Antibody-mediated capture of amyloid-beta (Aβ) in peripheral blood was identified as an
attractive strategy to eliminate cerebral toxic amyloid in Alzheimer's disease (AD) patients …
attractive strategy to eliminate cerebral toxic amyloid in Alzheimer's disease (AD) patients …